Summary
Addiction medicine doctor Dr. Casey Grover reviews a systematic review of clinical trials examining NAC for cannabis use disorder. The paper by Rishi Sharma analyzed eight randomized controlled trials and found mixed but promising results. NAC appears more consistently beneficial in adolescents, with multiple studies showing reduced cannabis use and increased cessation rates. The episode explains NAC's mechanism of action through glutamatergic transmission, where it helps reverse damage to the brain's reward center caused by excessive glutamate stimulation from addiction. NAC was dosed at 2400mg per day across all studies and found to be safe with minimal side effects.
Key Points
- NAC is an antioxidant derived from the amino acid cysteine involved in glutathione synthesis
- NAC affects glutamatergic transmission, helping reverse addiction-related damage to the brain's reward center (nucleus accumbens)
- A systematic review of 8 RCTs found mixed but promising results for NAC in cannabis use disorder
- NAC showed more consistent benefits in adolescents, with multiple studies showing reduced cannabis use
- All studies used 2400mg per day (1200mg twice daily) dosing
- NAC was found to be safe with minimal adverse effects across all studies
- An estimated 22 million people globally have cannabis use disorder with no FDA-approved medications
- NAC has also shown efficacy in treating cocaine, methamphetamine, alcohol, and nicotine addiction
Key Moments
NAC reverses addiction-related brain damage through glutamate regulation
Dr. Grover explains that repeated substance use causes excessive glutamate in the brain's reward center (nucleus accumbens), damaging neurons. NAC reverses some of this damage by upregulating glutamate transporters and acting as a potent antioxidant to remove excess glutamate.
"Nac, by being a potent antioxidant, is thought to have the potential to reverse some of the damage caused by too much glutamate with addiction in the reward center of the brain, and NAC also upregulates the glutamate transporter in the reward center of the brain as well, allowing the excess glutamate in the state of addiction to be removed"
Systematic review of 8 RCTs finds NAC more effective in adolescents for cannabis use
The review found that the first RCT of 116 adolescents showed NAC patients were 2.4 times more likely to have a negative cannabis urine test. A study of 54 adolescents showed reduced impulsivity and higher likelihood of negative urine tests. Results in adults were more variable.
"The first study was a randomized controlled trial of 116 adolescents and young adults with cannabis dependence, which showed a significant decrease in cannabis use in the NAC group as compared to placebo. They found that patients treated with NAC were more likely to have a urine drug test that was negative for cannabis as compared to placebo, and it was statistically significant with an odds ratio of 2.4."
NAC dosing is 2400mg per day with minimal side effects
All eight studies used the same dose of 2400mg per day, taken as 1200mg orally twice daily. NAC was found to be safe with minimal adverse effects, and in one study, serious side effects were actually more common in the placebo group than the NAC group.
"In terms of the dosing of NAC, it was the same in every study it was 2400 milligrams per day."
